Ascletis Pharma Inc. v. Itc

Case: 25-2164 Document: 25 Page: 1 Filed: 07/14/2026

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit

______________________

VIKING THERAPEUTICS, INC.,

Appellant v.

INTERNATIONAL TRADE COMMISSION,

Appellee ASCLETIS PHARMA INC., ASCLETIS PHARMACEUTICALS CO. LTD., ASCLETIS BIOSCIENCE CO., LTD., GANNEX PHARMA CO.,

LTD., JINZI JASON WU,

Intervenors ______________________

2025-2162 ______________________

Appeal from the United States International Trade Commission in Investigation No. 337-TA-1352.

-------------------------------------------------- ASCLETIS PHARMA INC., ASCLETIS PHARMACEUTICALS CO. LTD., ASCLETIS BIOSCIENCE CO., LTD., GANNEX PHARMA CO.,

LTD., Appellants v.

Case: 25-2164 Document: 25 Page: 2 Filed: 07/14/2026 2 ASCLETIS PHARMA INC. v. ITC

INTERNATIONAL TRADE COMMISSION,

Appellee VIKING THERAPEUTICS, INC.

Intervenor ______________________ 2025-2164 ______________________

Appeal from the United States International Trade Commission in Investigation No. 337-TA-1352.

______________________ ON MOTION ______________________

Before PROST, MAYER, and STOLL, Circuit Judges. MAYER, Circuit Judge.

ORDER

The International Trade Commission moves to dismiss Viking Therapeutics, Inc.’s cross-appeal, No. 2025-2162. The Commission states that Ascletis Pharma Inc. et al. (collectively, “Ascletis”) and Jinzi Jason Wu support the motion. The Commission indicates that Viking does not oppose the motion and “agrees that a panel of this Court would properly dismiss Viking’s cross-appeal,” but that Vi- king purportedly “reserves all rights to challenge the dis- missal of the cross-appeal in future proceedings.” ECF No. 21 at 2.

Upon consideration thereof, IT IS ORDERED THAT: (1) The motion to dismiss Appeal No. 2025-2162 is granted. Appeal No. 2025-2162 is deconsolidated and Case: 25-2164 Document: 25 Page: 3 Filed: 07/14/2026 ASCLETIS PHARMA INC. v. ITC 3 dismissed. The revised official captions are reflected in this order.

(2) Costs in Appeal No. 2025-2162 are taxed against the appellant.

(3) The Clerk of Court shall transmit a copy of this or- der to the merits panel assigned to Appeal No. 2025-2164.

FOR THE COURT July 14, 2026

Date ISSUED AS A MANDATE (as to Appeal No. 2025-2162 only): July 14, 2026